Clinical Trial Update: The Use of cineMRI to Evaluate Botox in Patients With Medication Refractory Overactive Bladder [NA]

View source ↗

Summary

A clinical trial update investigating cineMRI to evaluate the effect of Botox (onabotulinumtoxinA) in patients with medication-refractory overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Overactive Bladder | NA | Status: UNKNOWN